Instruments to measure the quality of life in patients with oral mucositis undergoing oncological treatment: a systematic review of the literature

Gutiérrez-Vargas, Rosaura; Díaz-García, María Luisa; Villasís‐Keever, Miguel Angel; Portilla‐Robertson, Javier; Zapata‐Tarrés, Marta

doi:10.1016/j.bmhime.2017.11.044

Cited by 1 publication

(1 citation statement)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, radiotherapy (RT) or intensified CRT can cause acute mucositis of the oral cavity, pharynx, and larynx in HNSCC patients, which poses a significant clinical problem (6,7). After the initiation of chemotherapy (CT) and/or RT, mucositis appears within 3-10 days in labial and buccal mucosa, the tongue, the floor of the mouth and soft palate (8). This often results in acute oral pain, hampered nutritional intake, and a compromised quality of life of the patients (9).…”

Section: Introductionmentioning

confidence: 99%

The Elental� elemental diet for chemoradiotherapy‑induced oral mucositis: A prospective study in patients with oral squamous cell carcinoma

et al. 2018

View full text Add to dashboard Cite

Oral mucositis is a common adverse effect of cancer treatment that can increase the risk for local and systemic infection. This prospective study was designed to evaluate the preventive effects of an amino-acid-rich elemental diet (ED), Elental ® , on radiotherapy-or chemoradiotherapy-induced mucositis in oral squamous cell carcinoma (OSCC) patients. Fifty patients were enrolled in this prospective study, who had received radiation (60-70 Gy) with/without chemotherapy [S-1, UFT, cisplatin (CDDP), docetaxel (DOC) plus CDDP, or Cetuximab]. The Elental ® group (25 patients) had received Elental ® during treatment, and the control group (25 patients) had not. Multivariate logistic regression analysis was used to identify the factors related to abatement of oral mucositis. A comparison of the rates of completion of chemoradiation treatments as well as the nutritional or inflammatory status between Elental ® and control groups was performed. Multivariate analysis indicated that most of the patients who received Elental ® suffered from a lower degree of mucositis and showed significantly improved rate of completion of chemoradiation (no interruption) compared to the control group. There was a significant difference between the Elental ® group and the control group in terms of the mean change of C-reactive protein (CRP) levels in blood serum; however, there was no significant difference in terms of a mean change of body weight and total protein level in blood serum before and after chemoradiation. Our study shows that the Elental ® elemental diet could be useful for the treatment of oral mucositis induced by chemoradiation. Elental ® might also promote improved completion rates of chemoradiotherapy in OSCC patients.

show abstract

Section: Introductionmentioning

confidence: 99%